Pulmonary 15NO uptake in interstitial lung disease

Area of Science:

• Pulmonary Physiology
• Respiratory Medicine
• Isotope Tracers

Background:

• Lung nitric oxide diffusing capacity (DLNO) assesses alveolar-capillary gas exchange.
• Interstitial lung disease (ILD) can cause significant pulmonary gas exchange disturbances.
• The utility of NO diffusing capacity in ILD requires further investigation.

Purpose of the Study:

• To evaluate if nitric oxide (NO) diffusing capacity measurements can appropriately reflect pulmonary gas exchange impairments in patients with interstitial lung disease (ILD).
• To assess the feasibility of using a stable isotope labeled nitric oxide ((15)NO) to measure DLNO, bypassing endogenous NO production.

Main Methods:

• A pilot study involving 10 outpatients with ILD.
• Measurement of DLNO using a single-breath method with (15)N-labeled NO.
• Assessment of standard lung function parameters and arterial oxygen partial pressure (PaO(2)).

Main Results:

• DLNO values ranged from 50-151 ml (15)NO/(mmHg min).
• Ratios of DLNO to predicted values (from healthy volunteers) were between 43% and 108%.
• A significant reduction in DLNO/reference was observed in five patients, correlating with PaO(2) levels.

Conclusions:

• (15)NO is a suitable indicator gas for measuring lung nitric oxide diffusing capacity.
• (15)NO-DLNO measurements can accurately reflect ILD-induced impairments in alveolar-capillary gas exchange.
• This technique shows promise for assessing disease severity and gas exchange abnormalities in ILD.